NCT00757458 - Evaluation of Bacterial and Fungal Contamination During Propofol Continuous Infusion | Biotech Hunter

Enrollment

652

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2009

Conditions

Drug Contamination

Interventions

DRUG

EDTA without re-filling

Target controlled infusion of propofol containing EDTA (Diprivan®-Astra Zeneca) using equipment Diprifusor® (Astra Zeneca), without re-filling of syringe.

OTHER

Propofol syringe re-filling with propofol containing EDTA

Target controlled infusion of propofol (Diprivan®-Astra Zeneca) using equipment Diprifusor® (Astra Zeneca) with re-filling of syringe with propofol containing EDTA.

OTHER

Target controlled infusion of propofol without EDTA

Target controlled infusion of propofol without EDTA using Marshal´s technic with Alaris® or Fresenius® equipment

OTHER

Re-filling of syringe with propofol without EDTA

Target controlled infusion of propofol (Diprivan®-Astra Zeneca) using equipment Diprifusor® (Astra Zeneca) with re-filling of syringe with propofol not containing EDTA.

Trial Locations (1)

05403-000

Universidade de Sao Paulo Hospital das Clinicas, São Paulo